Educational information, not medical advice — ask your doctor or midwife.
Track Gamma-Linolenic Acid (GLA) with reminders and record whether it helped, in the app.
Gamma-linolenic acid (GLA) is an omega-6 polyunsaturated fatty acid that sits at a key branch point in the body's fat metabolism pathway. Unlike most omega-6 fats, GLA acts more like omega-3s in the body — it converts into compounds that actively calm inflammation rather than promote it. It's found naturally in the seed oils of evening primrose, borage, and black currant plants.
Once absorbed, GLA is converted in the body to dihomo-gamma-linolenic acid (DGLA), which then produces prostaglandin E1 — a powerful compound that helps reduce inflammation, support healthy skin barriers, and ease hormonal symptoms. This pathway is distinct from the more common omega-6 route that can fuel inflammation, making GLA's anti-inflammatory effects somewhat unique among omega-6 fatty acids.
Most people get GLA through evening primrose oil capsules because they are widely available and well-studied, though borage oil delivers more GLA per capsule and may require fewer pills to reach therapeutic doses. Black currant seed oil also provides a balanced mix of omega-3 and omega-6 fatty acids alongside GLA. Liquid oils exist but are less convenient for consistent dosing.
Evening primrose, the most common GLA source, has been used by Indigenous North American peoples for centuries as a food and medicinal plant. Scientific interest in GLA as a therapeutic compound picked up strongly in the 1970s–1980s when British researchers began studying its role in eczema, PMS, and inflammatory disease. Borage has a long history in European herbal medicine, and black currant seed oil has been used in traditional Northern European wellness practices.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.